, Tuberculosis. Nature, vol.502, issue.7470, p.1, 2013.
, , 2019.
Evolution of mycobacterium tuberculosis: new insights into pathogenicity and drug resistance, Microbiol Spectr, vol.4, issue.5, 2016. ,
The nature and evolution of genomic diversity in the mycobacterium tuberculosis complex, Adv Exp Med Biol, vol.1019, pp.1-26, 2017. ,
, Nat Rev Dis Primers, vol.2, p.16076, 2016.
Mycobacterium tuberculosis complex members adapted to wild and domestic animals, Adv Exp Med Biol, vol.1019, pp.135-54, 2017. ,
A new evolutionary scenario for the Mycobacterium tuberculosis complex, Proc Natl Acad Sci, vol.99, issue.6, pp.3684-3693, 2002. ,
TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages, Nat Commun, vol.11, issue.1, p.684, 2020. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02473990
Variable host-pathogen compatibility in Mycobacterium tuberculosis, Proc Natl Acad Sci, vol.103, issue.8, pp.2869-73, 2006. ,
Genome plasticity of BCG and impact on vaccine efficacy, Proc Natl Acad Sci, vol.104, issue.13, pp.5596-601, 2007. ,
Deletion of RD1 from Mycobacterium tuberculosis mimics bacille CalmetteÀGuerin attenuation, J Infect Dis, vol.187, issue.1, pp.117-140, 2003. ,
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti, Mol Microbiol, vol.46, issue.3, pp.709-726, 2002. ,
Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death, PLoS Pathog, vol.8, issue.2, p.1002507, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01899479
tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells, Cell, vol.129, issue.7, pp.1287-98, 2007. ,
A historical and molecular phylogeny of BCG strains, Vaccine, vol.17, issue.7À8, pp.915-937, 1999. ,
Influence of BCG vaccine strain on the immune response and protection against tuberculosis, FEMS Microbiol Rev, vol.32, issue.5, pp.821-862, 2008. ,
Mycobacterial virulence: impact on immunogenicity and vaccine research, F1000 Faculty Rev, vol.8, 2019. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02615238
Tuberculosis vaccine development: progress in clinical evaluation, Clin Microbiol Rev, vol.33, issue.1, 2019. ,
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials, Vaccine, vol.31, issue.42, pp.4867-73, 2013. ,
PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence, PLoS One, vol.3, issue.10, p.3496, 2008. ,
The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis, Mol Microbiol, vol.60, issue.2, pp.312-342, 2006. ,
Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator, Proc Natl Acad Sci, vol.111, issue.31, pp.11491-11497, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02325922
The PhoP-dependent ncRNA MCR7 modulates the TAT secretion system in Mycobacterium tuberculosis, PLoS Pathog, vol.10, issue.5, p.1004183, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02325930
Control of M. tuberculosis ESAT-6 secretion and specific t cell recognition by PhoP, PLoS Pathog, vol.4, issue.2, p.33, 2008. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01370872
The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis, J Biol Chem, vol.281, issue.3, pp.1313-1319, 2006. ,
Comparative metabolomics between Mycobacterium tuberculosis and the MTBVAC vaccine candidate, ACS Infect Dis, vol.5, issue.8, pp.1317-1343, 2019. ,
Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier, J Biol Chem, vol.276, issue.23, pp.19845-54, 2001. ,
Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice, Nature, vol.402, issue.6757, pp.79-83, 1999. ,
Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant, Clin Exp Immunol, vol.141, issue.1, pp.21-29, 2005. ,
ESX-1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis, Cell Microbiol, vol.19, issue.7, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02326055
MTBVAC: attenuating the human pathogen of tuberculosis (TB) toward a promising vaccine against the TB epidemic, Front Immunol, vol.8, p.1803, 2017. ,
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis, Nat Commun, vol.8, p.16085, 2017. ,
Immunological responses and protective immunity against tuberculosis conferred by vaccination of BALB/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain, Clin Exp Immunol, vol.147, issue.2, pp.330-338, 2007. ,
Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant, Vaccine, vol.27, issue.18, pp.2499-505, 2009. ,
The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs, Vaccine, vol.24, issue.17, pp.3408-3427, 2006. ,
85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques, PLoS One, vol.4, issue.4, p.5264, 2009. ,
MTBVAC from discovery to clinical trials in tuberculosis-endemic countries, Expert Rev Vaccines, vol.16, issue.6, pp.565-76, 2017. ,
Safety of human immunisation with a liveattenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial, Lancet Respiratory Med, vol.3, issue.12, pp.953-62, 2015. ,
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial, Lancet Respiratory Med, vol.7, issue.9, pp.757-70, 2019. ,
Deciphering the role of IS6110 in a highly transmissible Mycobacterium tuberculosis Beijing strain, GC1237, Tuberculosis, vol.91, issue.2, pp.117-143, 2011. ,
Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope, Mol Microbiol, vol.31, issue.5, pp.1573-87, 1999. ,
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature, vol.393, issue.6685, pp.537-581, 1998. ,
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology, JAMA, vol.282, issue.24, pp.2321-2328, 1999. ,
Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics, Infect Immun, vol.66, issue.5, pp.2221-2230, 1998. ,
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products, Proc Natl Acad Sci, vol.97, issue.12, pp.6640-6645, 2000. ,
Recombineering in Mycobacterium tuberculosis, Nat Methods, vol.4, issue.2, pp.147-52, 2007. ,
Functional expression of the FLP recombinase in Mycobacterium bovis BCG, Gene, vol.399, issue.2, pp.112-121, 2007. ,
PPE and PE_PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX ,
, Mol Microbiol, vol.73, issue.3, pp.329-369, 2009.
RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection, PLoS Pathog, vol.14, issue.6, p.1007139, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02046090
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage, Nat Genet, vol.47, issue.3, pp.242-251, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01153552
A specific polymorphism in Mycobacterium tuberculosis H37Rv causes differential ESAT-6 expression and identifies WHIB6 as a novel ESX-1 component, Infect Immun, vol.82, issue.8, pp.3446-56, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02618736
Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex. Implications for pathogenesis and virulence, J Biol Chem, vol.277, issue.24, pp.21598-603, 2002. ,
Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosis, Nat Microbiol, vol.3, issue.2, pp.181-189, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02046016
Evidence for a rapid rate of molecular evolution at the hypervariable and immunogenic Mycobacterium tuberculosis PPE38 gene region, BMC Evol Biol, vol.9, p.237, 2009. ,
, WHO. WHO end TB strategy. World Health Organization, 2015.
Recombinant BCG expressing ESX-1 of mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection, Cell Rep, vol.18, issue.11, pp.2752-65, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01503927
Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosis, Mucosal Immunol, vol.12, issue.3, pp.805-820, 2019. ,
Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis, 2019. ,
Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene, J Biol Chem, vol.277, issue.41, pp.38148-58, 2002. ,
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response, Nature, vol.431, issue.7004, pp.84-91, 2004. ,
Variable virulence and efficacy of bcg vaccine strains in mice and correlation with genome polymorphisms, Mol Therapy, vol.24, issue.2, pp.398-405, 2016. ,
Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains, Lancet Infectious Dis, vol.10, issue.2, pp.103-114, 2010. ,
Mycobacterium tuberculosis Beijing genotype: a template for success, Tuberculosis, vol.91, issue.6, pp.510-533, 2011. ,